Issue 1/2004

Inhibition of puromycin-induced apoptosis in breast cancer cells by IGF-I occurs simultaneously with increased protein synthesis (1 — 11)

G., SODERLUND, M., HAARHAUS, S., CHISALITA, H.J., ARNQVIST,

Polymorphisms at GSTM1 and GSTT1 gene loci and susceptibility to cervical cancer in Indian population (12 — 16)

N.S., MURTHY, A.B., MITRA, A., SHARMA, J.K., SHARMA,

Serum levels of interleukin-18 and nitrite+nitrate in renal cell carcinoma patients with different tumor stage and grade (25 — 29)

S., SOZEN, U., COSKUN, B., SANCAK, N., BUKAN, N., GUNEL, L., TUNC,

Oxidative DNA damage in relation to nutrition (30 — 33)

M., KRAJCOVICOVA-KUDLACKOVA, M., DUSINSKA,

Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer (34 — 37)

Z., PASIEKA, K., KUZDAK, W., CZYZ, H., STEPIEN, J., KOMOROWSKI,

Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma (38 — 43)

W.J., KRUSZEWSKI, R., RZEPKO, J., WOJTACKI, J., SKOKOWSKI, A., KOPACZ, K., DRUCIS,

Detection of the sentinel node in breast carcinoma using method of a single subcutaneous injection of radiopharmaceutical (44 — 48)

H., KRIZOVA, M., WALD, P., STRNAD, J., HERMANSKA, J., ZIMAK, P., VLCEK,

Fine needle aspiration cytology of benign breast disease. Markers of apoptosis and proliferation (49 — 55)

J., SWIATECKA, P., LAUDANSKI, J., DZIECIOL,

Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia (56 — 58)

K., DEDIC, P., ZAK,

Perioperative fractionated high-dose rate brachytherapy in the treatment of soft tissue sarcomas (59 — 63)

J., PETERA, R., NEUMANOVA, K., ODRAZKA, M., ONDRAK, R., SOUMAROVA, P., JANICEK, E., PROCHAZKA, T., KOHLOVA,

The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field (64 — 69)

P., MILECKI, T., PIOTROWSKI, M., DYMNICKA,

Leukemia-like syndrome in Balb/c mice infected with the lymphotropic gamma herpesvirus MHV-Šumava: an analogy to EBV infection (71 — 76)

J., MISTRIKOVA, M., MRMUSOVA-SUPOLIKOVA, J., RAJCANI,

Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21WAF1/cip1 (77 — 83)

M., HERMANOVA, Z., LUKAS, R., NENUTIL, J., BRAZDIL, I., KROUPOVA, L., KREN, M., PAZOURKOVA, M., RUZICKA, P., DITE,

Proto-oncogene c-myc in uterine cervix carcinogenesis (84 — 89)

S., BRYCHTOVA, T., BRYCHTA, E.*, SEDLAKOVA, Z., KOLAR,

Telomerase as a diagnostic and predictive marker in colorectal carcinoma (90 — 96)

J., MALASKA, Z., KUNICKA, M., BORSKY, M., SKLENICKOVA, M., NOVOTNA, L., FAJKUSOVA, J., ZALOUDIK, J., FAJKUS,

Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment (97 — 102)

J., KUSENDA, O., BABUSIKOVA,

Predictive value of SCC-Ag, CYFRA 21-1 and selected acute phase proteins in radiotherapy of pharyngeal and laryngeal cancer. A preliminary report (103 — 109)

J., KULPA, Z., STASIK, J., SKOLYSZEWSKI, E., WOJCIK, U., RYCHLIK, K., PUDELEK,

Allogeneic peripheral blood stem cell transplantations in children -- a single center experience (110 — 116)

S., SUFLIARSKA, J., HORAKOVA, I., BODOVA, J., MARTINKA, M., HRUBISKO, L., KOVACS, K., JANCOVICOVA, J., LUKAC,

Differential diagnosis of benign tumors and tumor-like lesions in the spine. Own cases and review of the literature (117 — 126)

S.M., KNOELLER, M., UHL, C.-P., ADLER, G.W., HERGET,

Combined effect of sodium selenite and campthotecin on cervical carcinoma cells (127 — 135)

E., RUDOLF, J., RADOCHA, M., CERVINKA, J., CERMAN,

Lung cancer risk among nonsmoking women in relation to diet and physical activity (136 — 143)

A., KUBIK, P., ZATLOUKAL, L., TOMASEK, N., PAUK, L., PETRUZELKA, I., PLESKO,

Small area variations of cancer mortality in Hong Kong -- the roles of health care and socio-economic status (144 — 149)

I.T.S., YU, T.W., WONG, S.L., WONG,

Extended pneumonectomy for non small cell lung cancer -- should we still do it? (150 — 154)

W., DYSZKIEWICZ, C., PIWKOWSKI, M., KASPRZYK, R., RAMLAU, J., ADAMCZAK, K., PAWLAK,

How the implementation of an in-vivo dosimetry protocol improved the dose delivery accuracy in head and neck radiotherapy (155 — 158)

J., MALICKI, M., LITOBORSKI, J., KIERZKOWSKI, G., KOSICKA,

Expression of glucose transporter GLUT-1 and estrogen receptors ER- ? and ER-ß in human breast cancer (164 — 168)

P., LAUDANSKI, M., KODA, L., KOZLOWSKI, J., SWIATECKA, M., WOJTUKIEWICZ, S., SULKOWSKI, S., WOLCZYNSKI,

Expression of the multidrug resistance-associated protein 1 (MRP1) and the lung resistance-related protein (LRP) in human lung cancer (169 — 174)

S., RYBAROVA, M., HAJDUKOVA, I., HODOROVA, M., KOCISOVA, A., BOOR, E., BRABENCOVA, P., KASAN, E., BIROS, J., MOJZIS, L., MIROSSAY,

Gene expression during camptothecin-induced apoptosis in human myeloid leukemia cell line ML-2 (175 — 180)

V., ULLMANNOVA, C., HASKOVEC,

Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia (181 — 187)

K., JAMROZIAK, P., SMOLEWSKI, B., CEBULA, A., SZMIGIELSKA-KAPLON, Z., DARZYNKIEWICZ, T., ROBAK,

Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells (188 — 192)

L., CIPAK, H., PAULIKOVA, L., NOVOTNY, M., JAROSOVA, P., RAUKO,

Genotoxicity evaluation of pesticide formulations containing alachlor and atrazine in multiple mouse tissues (blood, kidney, liver, bone marrow, spleen) by comet assay (198 — 203)

D., ZELJEZIC, V., GARAJ-VRHOVAC,

Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer* (204 — 208)

F., JANKU, Z., KLEIBL, J., NOVOTNY, P., TESAROVA, L., PETRUZELKA, B., MATOUS,

Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions (209 — 213)

U., COSKUN, N., BUKAN, B., SANCAK, N., GUNEL, S., OZENIRLER, A., UNAL, A., YUCEL,

Distribution of the extracellular matrix glycoproteins in ependymomas - an immunohistochemical study with follow-up analysis* (214 — 222)

J., ZAMECNIK, M., CHANOVA, M., TICHY, R., KODET,

Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait (223 — 227)

S. AL, BAHAR, R., PANDITA, K., BAVISHI, O., KREZE, S., NATH,

NF-kB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer (239 — 247)

M.A., ALTINOZ, R., KORKMAZ,

Increasing occurrence of urological cancers in Slovakia (248 — 254)

I., PLESKO, A., OBSITNIKOVA, M., CUNINKOVA, L., TOMASEK, D., STEFANAKOVA, A., KUBIK,

Lung cancer risk among Czech tin and uranium miners -- comparison of lifetime detriment* (255 — 260)

L., TOMASEK, H., ZARSKA,

Bactericidal capacity of platelets in gastric cancer patients (265 — 268)

Z., KAMOCKI, J., MATOWICKA-KARNA, Z., PIOTROWSKI, H., KEMONA,

Serum levels of soluble E-selectin in colorectal cancer (269 — 274)

A., UNER, Z., AKCALI, D., UNSAL,

Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer (275 — 284)

P., PLEVOVA, A., KREPELOVA, M., PAPEZOVA, E., SEDLAKOVA, R., CURIK, L., FORETOVA, M., NAVRATILOVA, J., NOVOTNY, J., ZAPLETALOVA, J., PALAS, J., NIESLANIK, J., HORACEK

Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients (293 — 299)

O., CELEN, I., KAHRAMAN, E., YILDIRIM, U., BERBEROGLU,

Advanced tracheal carcinoma -- a therapeutic significance of HDR brachytherapy in palliative treatment (313 — 318)

J., SKOWRONEK, T., PIOTROWSKI, W., MLYNARCZYK, R., RAMLAU,

Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation (319 — 324)

G., MELEN-MUCHA, E., BALCERCZAK, S., MUCHA, M., PANCZYK, S., LIPA, M., MIROWSKI,

Pentacyclic triterpenoic acids: new chemoprotective compounds (327 — 333)

A, VACHALKOVA, Z., OVESNA, K., HORVATHOVA, D., TOTHOVA,

Meta-analyses of clinical trials in patients with non-small cell lung cancer (334 — 340)

V., KOVAC, U., SMRDEL,

Influence of diet containing lyophilized Enterococcus faecium M-74 with organic selenium on tumor incidence in Apc1638N mice (341 — 344)

K., HLUBINOVA, B., RYCHLY, V., ALTANEROVA, L., EBRINGER, C., ALTANER,

The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells (345 — 351)

O., BABUSIKOVA, T., ZELEZNIKOVA,

Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients (352 — 357)

V. HABALOVA, J. SALAGOVIC, I. KALINA, J. STUBNA

Synergic effects of the cyclin-dependent kinase (CDK) inhibitor olomoucine and androgen-antagonist bicalutamide on prostatic cancer cell lines (358 — 367)

Z., KOLAR, J., KNILLOVA, J., BOUCHAL, A., HLOBILKOVA, M., STRNAD,

Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression (368 — 374)

A., ZAID, J.P., BUREAU, S., ABOUDKHIL, L., HENRY,

Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer (375 — 378)

C., KUROPKAT, A.A., DUENNE, U., HERZ, H., RENZ, J.A., WERNER,

Treatment of associated anemia in different hematological disorders with epoetin alpha (379 — 384)

V. MAISNAR, K. CHROUST

Radioguided occult lesion localization (ROLL) of the nonpalpable breast lesions (385 — 389)

J., ZGAJNAR, M., HOCEVAR, S., FRKOVIC-GRAZIO, K., HERTL, E., SCHWEIGER, N., BESIC,

Experimental lens-sparing optimization in therapeutic orbital irradiation with electron beams (390 — 394)

K., OYSUL, B., DIRICAN, M., BEYZADEOGLU, S., SURENKOK, Y., PAK,

Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562 (395 — 399)

L., NOVOTNY, A, VACHALKOVA, K., HORVATHOVA, D., TOTHOVA,

Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimens: detection of a high-risk lesion (400 — 404)

L., KREN, M., HERMANOVA, R., NENUTIL, P., DITE, J., FEIT, Z., PAVLOVSKY,

Taraxasterol and ß-sitosterol: new naturally compounds with chemoprotective/chemopreventive effects (407 — 414)

A, VACHALKOVA, Z., OVESNA, K., HORVATHOVA,

Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies (415 — 421)

K., POHLODEK, Š., GALBAVY, M., BARTOSOVA, V., MUCHA, K., HOLOMAN, J., PASTOREK, S., PASTOREKOVA,

Analysis of surface and cytoplasmic immunoglobulin light/heavy chains by flow cytometry using a lysed-whole-blood technique: Implications for the differential diagnosis of B-cell malignancies (422 — 430)

O. BABUSIKOVA, L. STEVULOVA

Cytotoxic activity of a podophyllotoxin-like lignan from Linum tauricum Willd (425 — 429)

N., VASILEV, G., MOMEKOV, M., ZAHARIEVA, S., KONSTANTINOV, P., BREMNER, M., HEINRICH, I., IONKOVA,

Diet containing fungal (13)-ß-D-glucan derivative exhibits protective effects against DNA lesions induced in freshly isolated rat cells (431 — 435)

M., LAZAROVA, J., LABAJ, Z., KOVACIKOVA, D., SLAMENOVA,

Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5- c]quinazolines (436 — 441)

S., JANTOVA, M., MIKULASOVA, M., THEISZOVA,

Effect of cytosine arabinoside and hydroxyurea on micronucleus formation induced by model clastogens in Chinese hamster V79 cells (442 — 449)

Z., VALOVICOVA, A., GABELOVA,

Repair of oxidative DNA lesions in blood lymphocytes isolated from Sprague-Dawley rats; the influence of dietary intake of lignin (450 — 455)

J., LABAJ, L., WSOLOVA, M., LAZAROVA, B., KOSIKOVA, D., SLAMENOVA,

Genetic imbalances in benign bone tumors revealed by comparative genomic hybridization (456 — 459)

T., OZAKI, D., WAI, K-L., SCHAEFER, G., GOSHAGER, W., BOECKER, B., DOCKHORN-DWORNICZAK, CH., POREMBA,

Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro (460 — 464)

A., BILIR, A.D., GUNERI, M.A., ALTINOZ,

Interrelationship between macrophage IL-12, IL-10 and NO secretion in expression of their tumoricidal activity (465 — 470)

K., KOZLOWSKA, M., ZARECZNA, M., CICHOREK,

Breast cancer and neoadjuvant therapy: any predictive marker? (471 — 480)

R., VYZULA, L., DUSEK, J., ZALOUDIK, R., R. DEMLOVA, D., KLIMES, Š., SELVEKEROVA,

Early nuclear alterations and immunohistochemical expression of Ki- 67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma (481 — 486)

A.M.L., MORENA, C.T.F., OSHIMA, L.H., GEBRIM, M.I., EGAMI, R.A., SEGRETO, V.P.C., TEIXEIRA,

Factors influencing outcome of surgery for stage I rectal cancer (487 — 490)

O., CELEN, E., YILDIRIM, U., BERBEROGLU,